166 related articles for article (PubMed ID: 38714935)
21. Association of
Bick AG; Akwo E; Robinson-Cohen C; Lee K; Lynch J; Assimes TL; DuVall S; Edwards T; Fang H; Freiberg SM; Giri A; Huffman JE; Huang J; Hull L; Kember RL; Klarin D; Lee JS; Levin M; Miller DR; Natarajan P; Saleheen D; Shao Q; Sun YV; Tang H; Wilson O; Chang KM; Cho K; Concato J; Gaziano JM; Kathiresan S; O'Donnell CJ; Rader DJ; Tsao PS; Wilson PW; Hung AM; Damrauer SM;
Circulation; 2019 Sep; 140(12):1031-1040. PubMed ID: 31337231
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
Adeyemo A; Esezobor C; Solarin A; Abeyagunawardena A; Kari JA; El Desoky S; Greenbaum LA; Kamel M; Kallash M; Silva C; Young A; Hunley TE; de Jesus-Gonzalez N; Srivastava T; Gbadegesin R
Am J Kidney Dis; 2018 Mar; 71(3):399-406. PubMed ID: 29277510
[TBL] [Abstract][Full Text] [Related]
23. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
[TBL] [Abstract][Full Text] [Related]
24. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
[TBL] [Abstract][Full Text] [Related]
25. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
Dorr CR; Freedman BI; Hicks PJ; Brown WM; Russell GB; Julian BA; Pastan SO; Gautreaux MD; Muthusamy A; Chinnakotla S; Hauptfeld V; Bray RA; Kirk AD; Divers J; Israni AK
PLoS One; 2016; 11(4):e0152775. PubMed ID: 27054572
[TBL] [Abstract][Full Text] [Related]
26. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
[TBL] [Abstract][Full Text] [Related]
28. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
29. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
[TBL] [Abstract][Full Text] [Related]
30. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
[TBL] [Abstract][Full Text] [Related]
31. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
32.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
33. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein L1 and Kidney Disease in African Americans.
Friedman DJ; Pollak MR
Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
[TBL] [Abstract][Full Text] [Related]
35. Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry.
Thakoordeen-Reddy S; Winkler C; Moodley J; David V; Binns-Roemer E; Ramsuran V; Naicker T
Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():129-133. PubMed ID: 32018194
[TBL] [Abstract][Full Text] [Related]
36. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
[TBL] [Abstract][Full Text] [Related]
37. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.
Estrella MM; Li M; Tin A; Abraham AG; Shlipak MG; Penugonda S; Hussain SK; Palella FJ; Wolinsky SM; Martinson JJ; Parekh RS; Kao WH
Clin Infect Dis; 2015 Feb; 60(4):646-52. PubMed ID: 25281610
[TBL] [Abstract][Full Text] [Related]
38. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
Sampson MG; Robertson CC; Martini S; Mariani LH; Lemley KV; Gillies CE; Otto EA; Kopp JB; Randolph A; Vega-Warner V; Eichinger F; Nair V; Gipson DS; Cattran DC; Johnstone DB; O'Toole JF; Bagnasco SM; Song PX; Barisoni L; Troost JP; Kretzler M; Sedor JR;
J Am Soc Nephrol; 2016 Mar; 27(3):814-23. PubMed ID: 26150607
[TBL] [Abstract][Full Text] [Related]
39. Association between
Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q
Elife; 2023 Oct; 12():. PubMed ID: 37882666
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
